Status:

RECRUITING

Transcranial Pulse Stimulation for Alzheimer's Disease

Lead Sponsor:

Chinese University of Hong Kong

Collaborating Sponsors:

Asia Pacific Institute of Healthy ageing

Associated medical supplies company limited

Conditions:

Alzheimer Dementia (AD)

Eligibility:

All Genders

60-90 years

Phase:

PHASE2

Brief Summary

TPS is a non-invasive therapeutic modality that uses focused, low-energy pulse stimulation to stimulate tissue regeneration and reduce inflammation. In the context of neurological disorders, it is hyp...

Detailed Description

This pilot randomized placebo-controlled trial investigates the effects of transcranial pulse stimulation in subjects with early Alzheimer's Disease (AD). The TPS/Sham-TPS is administered for the firs...

Eligibility Criteria

Inclusion

  • Adults who have been clinically diagnosed with Alzheimer's Disease in the early stage 2-6a according to the Functional Assessment Staging Test (In Appendix A)
  • The mental capacity to give informed consent for research is made by an experienced geriatrician based on Appendix A.
  • Aged 60-90 years old.
  • Able to make informed consent under assistance, which is witnessed and signed by a family caregiver.

Exclusion

  • Cannot understand Chinese.
  • Mentally incapacitated, unable to provide informed consent
  • Inability to remain still for 30 minutes
  • Lack of available family caregiver to answer questionnaires
  • Alcohol or substance dependence
  • Major neurological conditions, including:
  • Brain tumor
  • Brain aneurysm
  • Presence of any metal implants in the brain
  • Hemophilia or other blood clotting disorders
  • History of thrombosis

Key Trial Info

Start Date :

July 21 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT07143734

Start Date

July 21 2025

End Date

June 1 2026

Last Update

September 16 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese UNiversity of Hong Kong

Hong Kong, Hong Kong